Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
According to the latest research, the global Eosinophilic Esophagitis Drug market size was valued at USD 181.83 million in 2022 and is expected to expand at a CAGR of 9.03% during the forecast period, reaching USD 305.51 million by 2028.
Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn. Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.
The drug may have some side effects
The FDA currently has no drugs available to treat eosinophilic esophagitis. All drugs used in EoE prescriptions should be considered off-label and experimental. Currently topical steroids, such as fluticasone or budesonide, are the main drugs for the treatment of EoE. But for some patients, continued use of steroids by swallowing can cause side effects of Candida infection (yeast infection of the mouth and esophagus). In addition, some patients do not have obvious effects on steroid therapy, and they still need to rely on diet management to control their condition.
Strict regulatory policies in the pharmaceutical industry
The production of medicines must maintain high standards to ensure the strength of the active ingredients and the quality and purity of the final product. These standards ensure that safe and effective products are provided for patients. Therefore, most governments in the world have implemented regulations on pharmaceutical companies, and each country has strict regulations on the production and marketing of drugs. These regulations often extend the process of bringing new drugs to the market. However, because EoE is a rare chronic esophageal inflammatory disease, pharmaceutical companies can apply for orphan drug qualification. This is because the government encourages pharmaceutical companies to develop treatments for rare diseases. These incentives may include faster approval times and financial assistance.
Region Overview:
In 2022, the share of the Eosinophilic Esophagitis Drug market in North America stood at 43.25%.
Company Overview:
AstraZeneca is one of the major players operating in the Eosinophilic Esophagitis Drug market, holding a share of 32.59% in 2023.
AstraZeneca
AstraZeneca is a science-led global biopharmaceutical company dedicated to the discovery, development and commercialization of prescription drugs.
GSK
GlaxoSmithKline Plc is a healthcare company engaged in the research, development and production of drugs, vaccines and drugs.
Segmentation Overview:
By type, Budesonide segment accounted for the largest share of market in 2022.
Budesonide
Budesonide is a corticosteroid or steroid. Topical budesonide has a good effect on eosinophilic esophagitis. This treatment is called oral viscous budesonide (OVB).
Fluticasone
Fluticasone is a corticosteroid drug used to treat symptoms related to excessive immune responses caused by various diseases such as allergies and asthma. Fluticasone can safely and effectively induce remission in many patients with eosinophilic esophagitis (EoE). Generally, the drug is well tolerated. The main side effects may include hoarseness or sore throat, yeast infection in the esophagus (candida).
Application Overview:
The market's largest segment by application is the segment Hospitals, with a market share of 53.42% in 2022.
This report elaborates on the market size, market characteristics, and market growth of the Eosinophilic Esophagitis Drug industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Eosinophilic Esophagitis Drug. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Eosinophilic Esophagitis Drug Market Report Include:
Market Size Estimates: Eosinophilic Esophagitis Drug market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Eosinophilic Esophagitis Drug market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Eosinophilic Esophagitis Drug market
Segment Market Analysis: Eosinophilic Esophagitis Drug market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Eosinophilic Esophagitis Drug market situations and prospects in major and top regions and countries
Eosinophilic Esophagitis Drug Market
Eosinophilic Esophagitis Drug Industry Chain: Eosinophilic Esophagitis Drug market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Eosinophilic Esophagitis Drug Industry News, Policies by regions
Eosinophilic Esophagitis Drug Industry Porters Five Forces Analysis
Key players in the global Eosinophilic Esophagitis Drug market are covered in Chapter 2:
Bayer
AstraZeneca
GSK
Dr. Falk Pharma
Teva
In Chapter 6 and Chapter 9, on the basis of types, the Eosinophilic Esophagitis Drug market from 2018 to 2028 is primarily split into:
Budesonide
Fluticasone
Others
In Chapter 7 and Chapter 10, on the basis of applications, the Eosinophilic Esophagitis Drug market from 2018 to 2028 covers:
Hospitals
Clinics
Drugstore
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Eosinophilic Esophagitis Drug market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Eosinophilic Esophagitis Drug industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Eosinophilic Esophagitis Drug market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Eosinophilic Esophagitis Drug industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Eosinophilic Esophagitis Drug market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Eosinophilic Esophagitis Drug market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Eosinophilic Esophagitis Drug market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
2022
Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn. Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.
The drug may have some side effects
The FDA currently has no drugs available to treat eosinophilic esophagitis. All drugs used in EoE prescriptions should be considered off-label and experimental. Currently topical steroids, such as fluticasone or budesonide, are the main drugs for the treatment of EoE. But for some patients, continued use of steroids by swallowing can cause side effects of Candida infection (yeast infection of the mouth and esophagus). In addition, some patients do not have obvious effects on steroid therapy, and they still need to rely on diet management to control their condition.
Strict regulatory policies in the pharmaceutical industry
The production of medicines must maintain high standards to ensure the strength of the active ingredients and the quality and purity of the final product. These standards ensure that safe and effective products are provided for patients. Therefore, most governments in the world have implemented regulations on pharmaceutical companies, and each country has strict regulations on the production and marketing of drugs. These regulations often extend the process of bringing new drugs to the market. However, because EoE is a rare chronic esophageal inflammatory disease, pharmaceutical companies can apply for orphan drug qualification. This is because the government encourages pharmaceutical companies to develop treatments for rare diseases. These incentives may include faster approval times and financial assistance.
Region Overview:
In 2022, the share of the Eosinophilic Esophagitis Drug market in North America stood at 43.25%.
Company Overview:
AstraZeneca is one of the major players operating in the Eosinophilic Esophagitis Drug market, holding a share of 32.59% in 2023.
AstraZeneca
AstraZeneca is a science-led global biopharmaceutical company dedicated to the discovery, development and commercialization of prescription drugs.
GSK
GlaxoSmithKline Plc is a healthcare company engaged in the research, development and production of drugs, vaccines and drugs.
Segmentation Overview:
By type, Budesonide segment accounted for the largest share of market in 2022.
Budesonide
Budesonide is a corticosteroid or steroid. Topical budesonide has a good effect on eosinophilic esophagitis. This treatment is called oral viscous budesonide (OVB).
Fluticasone
Fluticasone is a corticosteroid drug used to treat symptoms related to excessive immune responses caused by various diseases such as allergies and asthma. Fluticasone can safely and effectively induce remission in many patients with eosinophilic esophagitis (EoE). Generally, the drug is well tolerated. The main side effects may include hoarseness or sore throat, yeast infection in the esophagus (candida).
Application Overview:
The market's largest segment by application is the segment Hospitals, with a market share of 53.42% in 2022.
This report elaborates on the market size, market characteristics, and market growth of the Eosinophilic Esophagitis Drug industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Eosinophilic Esophagitis Drug. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Eosinophilic Esophagitis Drug Market Report Include:
Market Size Estimates: Eosinophilic Esophagitis Drug market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Eosinophilic Esophagitis Drug market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Eosinophilic Esophagitis Drug market
Segment Market Analysis: Eosinophilic Esophagitis Drug market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Eosinophilic Esophagitis Drug market situations and prospects in major and top regions and countries
Eosinophilic Esophagitis Drug Market
Competitive Landscape
and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product/service profile and recent development/updates, etc.Eosinophilic Esophagitis Drug Industry Chain: Eosinophilic Esophagitis Drug market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Eosinophilic Esophagitis Drug Industry News, Policies by regions
Eosinophilic Esophagitis Drug Industry Porters Five Forces Analysis
Key players in the global Eosinophilic Esophagitis Drug market are covered in Chapter 2:
Bayer
AstraZeneca
GSK
Dr. Falk Pharma
Teva
In Chapter 6 and Chapter 9, on the basis of types, the Eosinophilic Esophagitis Drug market from 2018 to 2028 is primarily split into:
Budesonide
Fluticasone
Others
In Chapter 7 and Chapter 10, on the basis of applications, the Eosinophilic Esophagitis Drug market from 2018 to 2028 covers:
Hospitals
Clinics
Drugstore
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Eosinophilic Esophagitis Drug market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Eosinophilic Esophagitis Drug industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Eosinophilic Esophagitis Drug market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Eosinophilic Esophagitis Drug industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Eosinophilic Esophagitis Drug market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Eosinophilic Esophagitis Drug market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Eosinophilic Esophagitis Drug market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
